Bullous Skin Rash: A Rare Case of Palbociclib-Induced Dermatological Toxicity

Palbociclib is an FDA-approved cyclin-dependent kinase inhibitor to treat hormone-positive, HER2-negative metastatic breast cancer. Severe skin toxicities are rare but important adverse events associated with these agents. Early detection of severe forms of skin lesions is crucial to permit the imme...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Noman Ahmed Jang, Alsharedi, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474565/
https://www.ncbi.nlm.nih.gov/pubmed/32913695
http://dx.doi.org/10.7759/cureus.10229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474565/
https://www.ncbi.nlm.nih.gov/pubmed/32913695
http://dx.doi.org/10.7759/cureus.10229

Ejemplares similares